AMD - AGE-RELATED MACULAR DEGENERATION
Clinical trials for AMD - AGE-RELATED MACULAR DEGENERATION explained in plain language.
Never miss a new study
Get alerted when new AMD - AGE-RELATED MACULAR DEGENERATION trials appear
Sign up with your email to follow new studies for AMD - AGE-RELATED MACULAR DEGENERATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Stem cells injected into eye aim to halt blindness in AMD patients
Disease control Not yet recruitingThis early-stage study tests whether transplanting lab-grown retinal cells (made from stem cells) into the eye is safe for people with late-stage age-related macular degeneration (AMD). Nine adults aged 50 to 80 will receive the cell injection under the retina. The main goal is t…
Matched conditions: AMD - AGE-RELATED MACULAR DEGENERATION
Phase: PHASE1, PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated May 26, 2026 05:31 UTC
-
Can red light slow vision loss from dry AMD?
Disease control Not yet recruitingThis study tests a new, non-invasive treatment for dry age-related macular degeneration (AMD), a common cause of vision loss. About 94 adults aged 50 and older with dry AMD will use a red-light device at home for 3 minutes twice daily, 5 days a month for 3 months. Researchers wil…
Matched conditions: AMD - AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated May 26, 2026 05:29 UTC
-
Laser light shows promise for slowing AMD vision loss
Disease control Not yet recruitingThis study tests a non-invasive laser treatment called photobiomodulation (PBM) in 67 people with early age-related macular degeneration (AMD) who have reticular pseudodrusen. The laser uses specific light wavelengths to stimulate cells and reduce inflammation. Participants are r…
Matched conditions: AMD - AGE-RELATED MACULAR DEGENERATION
Phase: NA • Sponsor: Fondazione G.B. Bietti, IRCCS • Aim: Disease control
Last updated May 22, 2026 13:53 UTC